2002

Nov 25, 2002
Guidant Applauds HHS Advisory Committee's Regulatory Reform Recommendations

Reforms to Promote Patient Access to Advanced Medical Technologies Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease,...

Nov 22, 2002
Guidant Invests in Developer of Minimally Invasive Devices for Treatment of Lung Disease

Spiration''s Solutions Represent Potential New Treatments for Emphysema and Lung Cancer Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and...

Nov 21, 2002
Landmark Heart Failure Therapy Study Sponsored by Guidant Achieves Primary Endpoint

COMPANION Study Stopped Due to Significant Reduction in Combined All-Cause Mortality and All-Cause Hospitalization Cardiac Resynchronization Therapy Defibrillator Arm Demonstrated Significant...

Nov 20, 2002
National Coverage Decision for Implantable Defibrillators Referred to Medicare Coverage Advisory Committee

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today reported that the Center for Medicare and Medicaid Services...

Nov 18, 2002
Guidant Introduces Innovative Next-Generation Stabilization Platform for Beating Heart Surgery

New System Designed to Simplify the Beating Heart Procedure Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and...

Show 5102550100 per page
Top